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GENE EXPRESSION MODULATION SYSTEM 
FOR USE IN PLANTS AND METHOD FOR 
MODULATING GENE EXPRESSION IN 
PLANTS 
RELATED APPLICATIONS 
This application is a continuation-in-part of US. patent 
application Ser. No. 11/491,690 ?led Jul. 24, 2006 noW aban 
doned, Which is incorporated herein by this reference. US. 
patent application Ser. No. 11/461,690 claims priority to US. 
Provisional Patent Application Ser. No. 60/702,047 ?led on 
Jul. 22, 2005, Which is also incorporated herein by this refer 
ence. 
TECHNICAL FIELD 
The present invention relates to the ?eld of gene expres 
sion, and, more particularly, to chemically-inducible systems 
that activate or inactivate gene expression in host plant cells. 
INTRODUCTION 
A gene sWitch is a chemically inducible system that acti 
vates or inactivates gene expression in host cells. Generally, 
gene sWitches, or gene regulation systems, are based on the 
interaction of a chemical inducer With speci?cally designed 
receptors or transcription factors. Such gene regulation sys 
tems generally have tWo transcription units and regulate a 
target gene in the folloWing manner. The product of the ?rst 
transcription unit is a transcription factor (activator or repres 
sor protein), Which is synthesized under the control of a 
particular promoter, e.g., cell-speci?c, tissue-speci?c, devel 
opmental-stage-speci?c promoter, to provide additional con 
trol. The second transcription unit includes a target promoter 
containing a response element sequence to Which the tran 
scription factor (activator or repressor protein) binds to acti 
vate or repress the expression of the target gene. An optimal 
gene regulation system should have loW or no basal expres 
sion in the absence of an inducer or ligand, and high induced 
expression in the presence of a Wide range of inducer or 
ligand concentrations. Also, an ideal system should involve a 
non-toxic inducer that can be easily applied, that is effective 
at loW levels, and that is speci?c to the gene of interest. 
Gene sWitches have a Wide range of uses. Over and under 
expression of genes can be accomplished using chemically 
inducible gene sWitches. For example, the glucocorticoid 
receptor (GR)-based sWitch Was used for dexamethasone 
inducible expression of bacterial avrRpt2 avirulence gene. 
Treatment of transgenic plants With dexamethasone led to 
cell-death response. See McNellis et al., Plant J 14:247-57 
(1998). 
Chemically-inducible gene sWitches also have utility in 
functional genomic applications, e.g., investigating gene 
function. For example, some plant genes that cause lethality 
at the early stages of development (eg Embryogenesis) may 
also play important roles at later stages of development. 
Mutations in such genes may lead to lethality at the early 
stages of development and make it impossible to study their 
function in later stages of development. HoWever, it is pos 
sible to introduce the appropriate coding sequence for a given 
mutation under the control of a gene sWitch that, in the pres 
ence of an inducer at the early stages of development, Will 
alloW plants to develop. Withdrawal of the inducer, at later 
stages of development, Will alloW studies on functions of 
these genes. For example, in Arabidopsis, the unusual ?oral 
organs (UFO) gene is required for ?oral development. Use of 
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2 
ethanol-inducible expression system to study the role of UFO 
by ubiquitously expressing it in ufo loss-of-function ?oWers 
at different developmental stages and for various lengths of 
time has alloWed ?oral phenotypes that Were not observed in 
loss-of-function backgrounds to be found. See Laufs, et al., 
Development 130: 785-796 (2003). 
Conditional regulation of transgene expression by the 
interaction of a chemical inducer With a designed receptor or 
transcription factor is a poWerful tool for determination of 
gene function and also for plant biotechnological applications 
(Aoyama and Chua, 1997; Koo et al. 2004; Martinez et al. 
1999; Padidam et al. 2003; SaeZ et al. 1997; WiaZ and Clay 
ton, 1995). The precise timing and control of gene expression 
are important aspects of chemically inducible gene regulation 
systems. 
The selective induction of gene expression is typically 
accomplished through the use of a promoter Whose transcrip 
tional activity is determined by the presence or absence of a 
speci?c inducer. By alloWing the time and location of gene 
expression to be precisely regulated, gene sWitches or induc 
ible promoters may control the deleterious and/or abnormal 
effects caused by over-expression, or under-expression, of 
genes and facilitate the understanding of gene function. 
Gene sWitches can also be used for identi?cation of doWn 
stream target genes. For example, an estrogen receptor (ER) 
gene sWitch has been used to regulate tWo transcription fac 
tors involved in ?avonoid pathWay for identi?cation of a 
number of a doWnstream target gene. See Bruce et al. Plant 
Cell 12:65-80 (2000). 
Gene sWitches can also be used for expression of antisense 
strands of genes for co-suppression studies. For example, an 
antisense strand of Arabiclopsis CDC2b gene Was expressed 
under the control of a GR-based sWitch. In transgenic plants 
induction of antisense RNA by dexamethaZone resulted in 
short hypocotyls and open cotyledons. See YoshiZumi et al. 
Plant Cell 11: 1883-96 (1999). Gene sWitches are also useful 
for the control of double stranded RNA production in gene 
suppression applications using RNAi. 
Gene sWitches can also be used for selection of transgenic 
plants Without the use of herbicides or antibiotics. Due to 
public concerns over the use of antibiotic or herbicide resis 
tance genes in transgenic plants and concerns over decrease in 
transformation e?iciency due to effect of herbicides and anti 
biotics on the groWth and regeneration of transformed cells, 
the production of marker-free transgenic plants has become a 
major objective for plant biologists. For example, a GR-based 
gene sWitch Was used in this manner to over express the 
isopentenyltransferase (ipt) gene from the Ti-plasmid of 
A grobaclerium Zumefaciens, Which led to an increase in gen 
eration of shoots from transformed plant cells in the presence 
of dexamethasone and the shoots developed into normal 
plants after WithdraWal of ligand. See Kunkel et al., Nat 
Biotechnol 17:9 16-9 (1999). 
Gene sWitches can also be used for e?icient spatial and 
temporal regulated expression of genes for pest resistance, 
herbicide resistance and trait improvement. For example, an 
ecdysone receptor (EcR)-based gene sWitch Was used to 
restore male fertility in maiZe. Ms45 maiZe gene that regu 
lates micro spore development Was placed under the control of 
EcR-based sWitch and introduced into ms45 mutant. A non 
steroidal agonist, methoxyfenoZide Was able to restore male 
fertility in these transgenic plants. See Unger et al. Transgenic 
Res 111455-65. 
Conditional gene regulation systems, based on the interac 
tion of a chemical inducer With a speci?cally designed recep 
tor or transcription factor, have been developed and tested in 
various plants and have proved poWerful tools for basic 
US 8,115,059 B1 
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research. However, the ligands that are often used are inap 
propriate for ?eld use; thus, they have little practical applica 
bility in agriculture. Gene sWitches developed for use in 
plants have been revieWed by Tang et al. Plant Science 166: 
827-834 and Padidam, Curr Opin Plant Bio 16: 169-77. 
Several chemical inducible gene regulation systems, or 
gene sWitches have been developed that respond to a variety 
of chemicals (Gatz et al, 1992; Wilde et al. 1992; Williams et 
al. 1992; Mett et al. 1993; Rieping et at 1994; Weinmann et al. 
1994;Aoyama and Chua 1997; Caddick et al. 1998; Bohner et 
al. 1999; Martinez et al. 1999a,b; Bruce et al. 2000, Zuo et al. 
2000; Padidam et al. 2003). Most of the systems are induced 
by compounds Which are not suitable for agriculture use. To 
overcome these problems, a more versatile chemical induc 
ible gene regulation system has been developed (Martinez et 
al. 1999 a,b; Padidam et al. 2003; Unger et al. 2002). The 
EcR-based gene regulation system is one of the best gene 
sWitch available because the chemical ligand required for its 
regulation, tubefenozide and methoxyfenozide, are already 
registered for ?eld use (see Palli et al. 2005a for recent 
revieWs). 
The advantages and/ or disadvantages associated With vari 
ous chemically inducible gene sWitches that have been devel 
oped to date have been discussed in recent revieWs (Padidam 
2003; Palli 2005; Tang et al. 2004; Wang and Negishi 2003, 
Zuo and Chua 2000). 
A chemical inducible gene regulation system that speci? 
cally regulates transgene expression in response to an exog 
enous inducer at a particular stage of plant development or in 
a speci?c organ is very valuable When using transgene Whose 
constitutive over expression is likely to compromise plant 
viability or fertility. In addition, gene sWitches are also useful 
in reducing the environmental concerns such as gene pollu 
tion and antibiotic resistance development associated With 
genetically modi?ed crops (Hare and Chua 2002; Palli 2005, 
Palli et al. 2005a). 
An ideal chemically inducible gene regulation system 
should support undetectable level of transgene expression in 
the absence of a chemical ligand folloWed by rapid and robust 
induction of transgene expression in the presence of loW 
concentration (nanomolar) of a chemical ligand. In an effort 
to ?nd an optimal gene sWitch, several approaches have been 
tried (Ainley and Key 1990; Schena et at 1991; Gatz et al. 
1992; Mett et al. 1993; Lloyd et al. 1994; Weinmann et al. 
1994; Aoyama and Chua 1997; Bruce et al. 2000; Zuo et al. 
2000). 
Ecdysone receptor (EcR)-based gene sWitches are desir 
able because the chemical ligands required for its regulation, 
tubefenozide and methoxyfenozide, are already registered for 
?eld use. Several ligand-binding domains from EcR of 
Drosophila melanogasler, Heliolhis virescens, Oslrina nubi 
lalis and Chorisloneurafumiferana have been used to create 
EcR-based gene regulation systems or sWitches. See e.g., 
Martinez etal. Plant] 19:97-106 (1999); Martinez et al. Mol. 
Gen. Genet. 261546-552 (1999); Unger et al. Transgenic Res 
11:455-465 (2002). 
Most knoWn EcR-based gene sWitches developed for 
plants require ligand concentrations in the HM levels for acti 
vation, Which creates a limitation to the use of the gene sWitch 
for large-scale agricultural applications. See e.g., Unger et al. 
Transgenic Res 1 1:455-465 (2002); and Padidam et al., 
Transgenic Res 12: 101-109 (2003); and Koo et al. Plant J37: 
439-448 (2004). Additionally, certain EcR-based gene 
sWitches that use an ultra spiracle receptor (USP) as a partner 
and have been shoWn to Work in plants are “leaky” in that they 
have a high background activity in the absence of ligand. See 
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US. Pat. Nos. 6,504,082; 5,880,333 and US. Publication 
Nos. 2003/0131381; 2003/10110528; 2002/0155540. 
An EcR gene sWitch With a potential for use in large-scale 
?eld applications and its applicability to a variety of plant 
species has been developed by adopting a tWo-hybrid format 
(Tavva et al. 2006). An EcR gene sWitch that uses CH9 as 
partner of CfEcR Which shoWs loW background activity in the 
absence of ligand and high induction of luciferase reporter 
gene in the presence of nanomolar concentration of methoxy 
fenozide ligand (Tavva et al. 2006). Use of CH9 having 1-8 
helices HsRXR has associated biosafety and social accep 
tance issues. 
Accordingly, there remains a need in the art for a gene 
sWitch that can be used in host plant cells that has loW or no 
basal expression in the absence of a ligand, has induced 
expression in the presence of a Wide range of ligand concen 
trations, and avoids biosafety and social acceptance issues. 
SUMMARY 
The presently-disclosed subject matter meets some or all of 
the above-identi?ed needs, as Will become evident to those of 
ordinary skill in the art after a study of information provided 
in this document. 
This Summary describes several embodiments of the pres 
ently-disclosed subject matter, and in many cases lists varia 
tions and permutations of these embodiments. This Summary 
is merely exemplary of the numerous and varied embodi 
ments. Mention of one or more representative features of a 
given embodiment is likeWise exemplary. Such an embodi 
ment can typically exist With or Without the feature(s) men 
tioned; likewise, those features can be applied to other 
embodiments of the presently-disclosed subject matter, 
Whether listed in this Summary or not. To avoid excessive 
repetition, this Summary does not list or suggest all possible 
combinations of such features. 
The presently-disclosed subject matter includes an ecdys 
one receptor (EcR)-based gene expression modulation sys 
tem for use in plants, Which has a tWo-hybrid format and 
makes use of a modi?ed retinoid x receptor (RXR) as a 
partner. The gene sWitch of the present invention has various 
utilities in plants. In this regard, the invention further a 
method of modulating gene expression in a host plant cell, 
Which is useful, for example, to investigate gene function or to 
select predetermined plants in an agricultural setting Without 
the use of herbicides and/or pesticides. 
The EcR-modi?ed RXR gene sWitch has little or no basal 
expression in the absence of a ligand, Works With a Wide range 
of concentrations, including nM concentrations of li gand, and 
Works in a variety of plant species. Additionally, the EcR 
modi?ed RXR gene sWitch Works With ligands that are 
already registered for ?eld use and are easily applied, making 
the gene sWitch useful for large-scale ?eld applications. 
The presently-disclosed subject matter includes a system 
for modulating expression of a gene-of-interest in a host plant 
cell. In some embodiments, the system can include an EcR 
gene expression cassette comprising a ?rst polynucleotide 
encoding a ?rst polypeptide; a modi?ed RXR gene expres 
sion cassette comprising a second polynucleotide encoding a 
second polypeptide; and a gene-of-interest expression cas 
sette for expressing the gene-of-interest in the host plant cell. 
The ?rst polypeptide expressed by the EcR gene expres 
sion cassette can include a DNA binding domain that recog 
nizes a response element of the gene of interest expression 
cassette; and a ligand binding domain from an EcR. 
The second polypeptide expressed by the modi?ed RXR 
gene expression cassette can include a transactivation domain 
US 8,115,059 B1 
5 
for activating a promoter of the gene of interest expression 
cassette, and; and a ligand binding domain of a modi?ed 
RXR, comprising a polypeptide sequence of SEQ ID NO: 1 
With at least one amino acid mutation. 
The ?rst and second polypeptides dimeriZe in the presence 
of a ligand. The DNA binding domain binds the response 
element of the gene-of-interest expression cassette, While the 
promoter of the gene-of-interest expression cassette is acti 
vated by the transactivation domain. As such, When the ?rst 
and second polypeptides dimeriZe, expression of the gene-of 
interest is affected in the host plant cell. 
In some embodiments of the system, the EcR ligand bind 
ing domain is a truncated EcR ligand binding domain. In 
some embodiments of the system, the EcR ligand binding 
domain is complete and can contain tWelve helices. In some 
embodiments of the system, the ligand binding domain of the 
EcR is a ligand binding domain selected from: a spruce bud 
Worm EcR, a moth EcR, a butter?y EcR, a ?y EcR, a mosquito 
EcR, a beetle EcR, a locust EcR, a White?y EcR, a fruit ?y 
EcR, a hone bee EcR, and a leaf hopper EcR. In some embodi 
ments of the system, the ligand binding domain of the EcR is 
from a spruce budWorm EcR. 
In some embodiments of the system, the DNA-binding 
domain and the response element are selected from: GAL4 
147 DNA-binding domain and response element; GAL4 65 
DNA-binding domain and response element; GAL4 93 DNA 
binding domain and response element; LexA DNA-binding 
domain and response element; and Lac repressor DNA-bind 
ing domain and response element. In some embodiments of 
the system, the DNA-binding domain and the response ele 
ment are GAL4 147 DNA-binding domain and response ele 
ment. 
In some embodiments of the system, the at least one amino 
acid mutation of the modi?ed RXR is selected from the group 
consisting of: S122A; A105S; T94A; T81H; A62S; A62S: 
T81H; and A62S:T81H:V123I. In some embodiments of the 
system, the RXR is a truncated RXR. In some embodiments, 
the RXR includes 1-12 helices. In some embodiments, the 
modi?ed RXR includes RXR from different species. In some 
embodiments, the modi?ed RXR includes RXR from a single 
species. In some embodiments, the ligand binding domain of 
the RXR is a ligand binding domain selected from: a migra 
tory locust RXR, a mouse RXR, a honey bee RXR, a beetle 
RXR, a White?y RXR, or a leaf hopper RXR. In some 
embodiments, the ligand binding domain of the RXR is not 
from human RXR. In some embodiments, the ligand binding 
domain of the RXR is from a migratory locust RXR. 
In some embodiments of the presently-disclosed subject 
matter, the transactivation domain of the second polypeptide 
encoded by the modi?ed RXR gene expression cassette is 
selected from: a VP16 activation domain; a GAL4 activation 
domain, a p53 activation domain, and a p65 subunit of Nf-kb 
activation domain. In some embodiments, the transactivation 
domain is a VP16 activation domain. 
In some embodiments of the system, the EcR gene expres 
sion cassette and the RXR gene expression cassette are under 
the control of constitutive promoters. In some embodiments, 
the constitutive promoters are selected from the group con 
sisting of: 35S promoters; CaMv promoters; and CSV pro 
moters. In some embodiments, the constitutive promoters of 
the EcR gene expression cassette and the RXR gene expres 
sion cassette are 35S promoters. 
In some embodiments of the system, the gene-of-interest 
expression cassette further includes a translational optimiZa 
tion sequence. In some embodiments, the translational opti 
miZation sequence comprises the sequence AACAATGGA. 
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In some embodiments of the system, the promoter of the 
gene-of-interest expression cassette is selected from: —46 35S 
promoter; or TATAA promoter. In some embodiments, the 
promoter of the gene-of-interest expression cassette is —46 
35S promoter. 
In some embodiments of the system, the ligand is selected 
from: a diacylhydraZine compound, methoxyfenoZide, tube 
fenoZide, halo fenoZide, and chromogenoZide. In some 
embodiments, the ligand is methoxyfenoZide. In some 
embodiments, the concentration of ligand for expressing the 
gene-of-interest is about 15 nM to about 100 nM. 
The presently-disclosed subject matter further includes a 
method of modulating expression of a gene-of-interest in a 
host plant cell. In some embodiments, the method includes 
introducing into the host plant cell a system for modulating 
expression of the gene-of-interest, and introducing into the 
host plant cell a ligand that binds the ligand-binding domain 
of the ?rst polypeptide. The system for modulating expres 
sion of the gene of interest can include an EcR gene expres 
sion cassette for expressing a ?rst polypeptide, including a 
binding domain that recogniZes a response element associ 
ated With the gene-of-interest, and a ligand binding domain 
from an EcR; and an RXR gene expression cassette for 
expressing a second polypeptide, including (i) a transactiva 
tion domain, and a ligand binding domain of a modi?ed RXR, 
comprising a polypeptide sequence of SEQ ID NO: 1 With at 
least one amino acid mutation; and a gene-of-interest expres 
sion cassette, including the response element to Which the 
binding domain binds, a promoter that is activated by the 
transactivation domain, and the gene of interest. 
In some embodiments of the method, the modi?ed RXR of 
the ligand binding domain of the second polypeptide includes 
at least one amino acid mutation is selected from the group 
consisting of: S122A; A105S; T94A; T81H; A62S; A62S: 
T81H; and A62S1T81H1V123I. 
In some embodiments of the method, the gene-of-interest 
expression cassette of the system further includes a transla 
tional optimiZation sequence. In some embodiments, the 
translational optimiZation sequence comprises the sequence 
AACAATGGA. 
The presently-disclosed subject matter further includes 
certain isolated nucleic acid molecules and isolated polypep 
tides. In some embodiments, an isolated nucleic acid com 
prising a sequence that encodes a polypeptide comprising 
SEQ ID NO: 1 With at least one amino acid mutation is 
provided. In some embodiments, an isolated polypeptide 
comprising SEQ ID NO: 1 With at least one amino acid 
mutation is provided. In some embodiments, the at least one 
amino acid mutation is selected from the group consisting of: 
S122A;A105S; T94A; T81H;A62S;A62S:T81H; andA62S: 
T81HzV123I. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 is a schematic representation of a gene expression 
modulation system for use in plants. 
FIG. 2 includes schematic representations of binary vec 
tors With different minimal promoters. p23001Lm71KLuczT 
DNA region of the pCAMBIA2300 binary vector shoWing 
the assembly of receptor and reporter expression cassettes. 
35S2 P CaMV 35S promoter With double enhancer sequence, 
T rbcs Poly A sequence, FMV P ?gWort mosaic virus pro 
moter, Ubi T ubiquitin 3 terminator, MMV P Mirabilis 
mosaic virus promoter OCS T Agrobaclerium Zumefaciens 
octopine synthase poly A. 
FIGS. 3A-3F are a series of bar graphs shoWing the results 
of a screening of different LmRXR mutants in transient 
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expression studies using tobacco protoplasts, including 
S122A (Lm-l) (FIG. 3A), A105S (Lm-2) (FIG. 3B), T94A 
(Lm-3) (FIG. 3C), T81H (Lm-4) (FIG. 3D), A62S (Lm-5) 
(FIG. 3E), and control (Wild type) (FIG. 3F). In order to 
determine the dose-dependent induction of the luciferase 
gene by EcR gene sWitches. Tobacco protoplasts Were elec 
troporated With pK80GCfE+pK80Lm mutants (Lm-1-Lm-5) 
and reporter construct. Electroporated protoplasts Were 
exposed to varying concentrations of methoxyfenoZide. 
Luciferase activity Was measured after 24 h of incubation and 
the values Were expressed as relative light units per micro 
gram protein. 
FIG. 4 is a bar graph comparing the dose-dependent induc 
tion of the luciferase gene by EcR gene sWitches containing 
Wild-type LmRXR, LmRXR mutant [Lm-6 (T81H:A62S)], 
and LmRXR mutant [Lm-7 (T81H:A62S:V123I)]. 
FIGS. 5A-5D are a series of bar graphs shoWing the dose 
dependent induction of the luciferase gene by EcR gene 
sWitches involving LmRXR, Where different translational 
optimiZation sequences Were integrated upstream to the cod 
ing region of luciferase gene; FIG. 5A includes the control, 
FIG. 5B includes the optimization sequence AACAATGGA, 
FIG. 5C includes the optimiZation sequence of 
AAAAATGGA, and FIG. 5D includes the optimiZation 
sequence of AACCATGGA. 
FIG. 6 is a bar graph comparing induction of luciferase in 
response to different doses of methoxyfenoZide by EcR gene 
sWitches containing the Lm-7 LmRXR mutant, CH9, and 
Wild-type LmRXR, each With the optimiZation sequence 
AACAATGGA. 
FIGS. 7A-7D are bar graphs comparing dose-response to 
ligand in T2 Arabidopsis plants including containing EcR 
gene sWitches containing the Lm-7 LmRXR mutant (FIGS. 
7A and 7B), Wild-type LmRXR (FIG. 7C), and CH9 (FIG. 
7D). 
FIGS. 8A-8C area series of bar graphs from a time-course 
induction of luciferase gene activity in T2 Arabidopsis plants 
containing EcR gene sWitches containing the Lm-7 LmRXR 
mutant (FIG. 8A), CH9 (FIG. 8B), and Wild-type LmRXR 
(FIG. 8C). Seedlings groWn on agar medium Without added 
methoxyfenoZide Were transferred to greenhouse. Different 
concentrations (0, 0.64, 3.2, 16, 80, 400, 2000, 10 000 nm) of 
ligand Was applied to soil. Samples Were collected at 0, 1, 2 
and 4 days after addition of ligand and luciferase activity Was 
measured in terms of RLU/ug protein. 
BRIEF DESCRIPTION OF THE SEQUENCE 
LISTING 
SEQ ID NO: 1 is an amino acid sequence from LmRXR. 
SEQ ID NO: 2 is a forWard primer used to make a S122A 
modi?cation to the amino acid of SEQ ID NO: 1 in the studies 
described in the Examples. 
SEQ ID NO: 3 is a reverse primer used to make a S122A 
modi?cation to the amino acid of SEQ ID NO: 1 in the studies 
described in the Examples. 
SEQ ID NO: 4 is a forWard primer used to make anA105S 
modi?cation to the amino acid of SEQ ID NO: 1 in the studies 
described in the Examples. 
SEQ ID NO: 5 is a reverse primer used to make an A105S 
modi?cation to the amino acid of SEQ ID NO: 1 in the studies 
described in the Examples. 
SEQ ID NO: 6 is a forWard primer used to make a T94A 
modi?cation to the amino acid of SEQ ID NO: 1 in the studies 
described in the Examples. 
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SEQ ID NO: 7 is a reverse primer used to make a T94A 
modi?cation to the amino acid of SEQ ID NO: 1 in the studies 
described in the Examples. 
SEQ ID NO: 8 is a forWard primer used to make a T81H 
modi?cation to the amino acid of SEQ ID NO: 1 in the studies 
described in the Examples. 
SEQ ID NO: 9 is a reverse primer used to make a T81H 
modi?cation to the amino acid of SEQ ID NO: 1 in the studies 
described in the Examples. 
SEQ ID NO: 10 is a forWard primer used to make anA62S 
modi?cation to the amino acid of SEQ ID NO: 1 in the studies 
described in the Examples. 
SEQ ID NO: 11 is a reverse primer used to make an A62S 
modi?cation to the amino acid of SEQ ID NO: 1 in the studies 
described in the Examples. 
SEQ ID NO: 12 is a forWard primer used to make a V123I 
modi?cation to the amino acid of SEQ ID NO: 1 in the studies 
described in the Examples. 
SEQ ID NO: 13 is a reverse primer used to make a V123I 
modi?cation to the amino acid of SEQ ID NO: 1 in the studies 
described in the Examples. 
SEQ ID NO: 14 is a forWard primer used to verify the 
integration of the AAAAATGGA sequence in the studies 
described in the Examples. 
SEQ ID NO: 15 is a forWard primer used to verify the 
integration of the AACCATGGA sequence in the studies 
described in the Examples. 
SEQ ID NO: 16 is a forWard primer used to verify the 
integration of the AACAATGG sequence in the studies 
described in the Examples. 
DESCRIPTION OF EXEMPLARY 
EMBODIMENTS 
The details of one or more embodiments of the presently 
disclosed subject matter are set forth in this document. Modi 
?cations to embodiments described in this document, and 
other embodiments, Will be evident to those of ordinary skill 
in the art after a study of the information provided in this 
document. The information provided in this document, and 
particularly the speci?c details of the described exemplary 
embodiments, is provided primarily for cleamess of under 
standing and no unnecessary limitations are to be understood 
therefrom. In case of con?ict, the speci?cation of this docu 
ment, including de?nitions, Will control. 
Some of the polynucleotide and polypeptide sequences 
disclosed herein are cross-referenced to GENBANK® acces 
sion numbers. The sequences cross-referenced in the GEN 
BANK® database are expressly incorporated by reference as 
are equivalent and related sequences present in GENBANK® 
or other public databases. Also expressly incorporated herein 
by reference are all annotations present in the GENBANK® 
database associated With the sequences disclosed herein. 
Unless otherWise indicated or apparent, the references to the 
GENBANK® database are references to the most recent ver 
sion of the database as of the ?ling date of this Application. 
While the terms used herein are believed to be Well under 
stood by one of ordinary skill in the art, de?nitions are set 
forth herein to facilitate explanation of the presently-dis 
closed subject matter. 
Unless de?ned otherWise, all technical and scienti?c terms 
used herein have the same meaning as commonly understood 
by one of ordinary skill in the art to Which the presently 
disclosed subject matter belongs. Although any methods, 
devices, and materials similar or equivalent to those described 
herein can be used in the practice or testing of the presently 
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disclosed subject matter, representative methods, devices, 
and materials are noW described. 
Following long-standing patent laW convention, the terms 
“a”, “an”, and “the” refer to “one or more” When used in this 
application, including the claims. Thus, for example, refer 
ence to “a cell” includes a plurality of such cells, and so forth. 
Unless otherWise indicated, all numbers expressing quan 
tities of ingredients, properties such as reaction conditions, 
and so forth used in the speci?cation and claims are to be 
understood as being modi?ed in all instances by the term 
“about”. Accordingly, unless indicated to the contrary, the 
numerical parameters set forth in this speci?cation and claims 
are approximations that can vary depending upon the desired 
properties sought to be obtained by the presently-disclosed 
subject matter. 
As used herein, the term “about,” When referring to a value 
or to an amount of mass, Weight, time, volume, concentration 
or percentage is meant to encompass variations of in some 
embodiments 120%, in some embodiments 110%, in some 
embodiments 15%, in some embodiments 11%, in some 
embodiments 10.5%, and in some embodiments 10.1% from 
the speci?ed amount, as such variations are appropriate to 
perform the disclosed method. 
The presently-disclosed subject matter includes systems 
and methods for modulating expression of a gene-of-interest 
in a host plant cell. 
As used herein, the term “modulate” refers to any change in 
expression of a gene of interest, including an increase or 
decrease in expression of a gene-of-interest. As such, modu 
lation of a gene-of-interest can include over-expressing, 
under-expressing, or substantially blocking expression of the 
gene-of-interest in a host plant cell. 
The term “gene” is used broadly to refer to any segment of 
DNA associated With a biological function. Thus, genes 
include, but are not limited to, coding sequences and/or the 
regulatory sequences required for their expression. Genes can 
also include non-expressed DNA segments that, for example, 
form recognition sequences for a polypeptide. Genes can be 
obtained from a variety of sources, including cloning from a 
source of interest or synthesizing from knoWn or predicted 
sequence information, and can include sequences designed to 
have desired parameters. Examples of genes that can be 
modulated in accordance With the presently-disclosed subject 
matter include, but are not limited to, the folloWing: insecti 
cidal genes, such as Bt and protease inhibitors; anti-bacterial 
and anti-fungal genes, such as defensin; genes toxic to or 
Which inhibit development of insects, pathogens, and nema 
todes; and the like. 
As used herein, the term “plant cell” is understood to mean 
any cell derived from a monocotyledonous or a dicotyledon 
ous plant. The term “plant” is understood to mean any differ 
entiated multicellular organism capable of photosyntheis, 
including monocotyledons and dicotyledons, With speci?c 
examples including, but not limited to: Arabidopsis, tobacco, 
corn, or soybean. 
The EcR-based system for modulating expression of a 
gene-of-interest (or gene sWitch) as described herein has a 
tWo-hybrid format and uses a modi?ed retinoid x receptor 
(RXR) as a partner. The EcR-RXR gene sWitch has little or no 
basal expression in the absence of a ligand, Works With a Wide 
range of concentrations, including nM concentrations of 
ligand, and Works in a variety of plant species. Additionally, 
the EcR-RXR gene sWitch Works With ligands that are already 
registered for ?eld use and are easily applied, making the gene 
sWitch useful for large-scale ?eld applications. 
In some embodiments of the presently-disclosed subject 
matter, the system includes an EcR gene expression cassette, 
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an RXR gene expression cassette, and a gene-of-interest 
expression cassette, each of Which are capable of being 
expressed in a host plant cell. 
The term “expression cassette” refers to a nucleic acid 
molecule capable of directing expression of a particular 
nucleotide sequence in an appropriate host cell, comprising a 
promoter operatively linked to the nucleotide sequence of 
interest Which is operatively linked to termination signals. It 
can also include sequences required for proper translation of 
the nucleotide sequence. The coding region usually encodes a 
polypeptide of interest but can also encode a functional RNA 
of interest, for example antisense RNA or a non-translated 
RNA, in the sense or antisense direction. The expression 
cassette comprising the nucleotide sequence of interest can be 
chimeric, meaning that at least one of its components is 
heterologous With respect to at least one of its other compo 
nents. The expression cassette can also be one that is naturally 
occurring but has been obtained in a recombinant form useful 
for heterologous expression. 
Typically, hoWever, the expression cassette is heterologous 
With respect to the host; i.e., the particular DNA sequence of 
the expression cassette does not occur naturally in the host 
cell and Was introduced into the host cell or an ancestor of the 
host cell by a transformation event. The expression of the 
nucleotide sequence in the expression cassette can be under 
the control of a constitutive promoter or of an inducible pro 
moter that initiates transcription only When the host cell is 
exposed to some particular external stimulus. In the case of a 
multicellular organism such as a plant, the promoter can also 
be speci?c to a particular tissue, organ, or stage of develop 
ment. 
The EcR gene expression cassette of the presently-dis 
closed subject matter includes a nucleotide sequence that 
encodes a ?rst polypeptide, While the RXR gene expression 
cassette includes a nucleotide sequence that encodes a second 
polypeptide. 
The terms “nucleotide” and “nucleic acid” refers to deox 
yribonucleotides or ribonucleotides and polymers thereof in 
either single or double stranded form. Unless speci?cally 
limited, the term encompasses nucleic acids containing 
knoWn analogues of natural nucleotides that have similar 
binding properties as the reference nucleic acid and are 
metaboliZed in a manner similar to naturally occurring nucle 
otides. Unless otherWise indicated, a particular nucleic acid 
sequence also implicitly encompasses conservatively modi 
?ed variants thereof (e.g., degenerate codon substitutions) 
and complementary sequences and as Well as the sequence 
explicitly indicated. Speci?cally, degenerate codon substitu 
tions can be achieved by generating sequences in Which the 
third position of one or more selected (or all) codons is sub 
stituted With mixed base and/or deoxyinosine residues 
(BatZer et al. (1 991) Nucleic Acid Res 19: 508 1; Ohtsuka et al. 
(1985) J Biol Chem 26012605 2608; Rossolini et al. (1994) 
Mol Cell Probes 8:91 98). 
As used herein, the term “polypeptide” means any polymer 
comprising any of the 20 protein amino acids, regardless of its 
siZe. Although “protein” is often used in reference to rela 
tively large polypeptides, and “peptide” is often used in ref 
erence to small polypeptides, usage of these terms in the art 
overlaps and varies. The term “polypeptide” as used herein 
refers to peptides, polypeptides, and proteins, unless other 
Wise noted. The term further encompasses fusion proteins. As 
used herein, the terms “protein”, “polypeptide,” and “pep 
tide” are used interchangeably When referring to a gene prod 
uct or amino acid produced using an expression cassette. 
The gene-of-interest expression cassette includes a 
response element and a promoter. The ?rst polypeptide 
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encoded by the EcR expression cassette includes a DNA 
binding domain that recognizes the response element of the 
gene-of-interest expression cassette. The ?rst polypeptide 
also includes a ligand binding domain, Which is capable of 
receiving a ligand. The second polypeptide includes a modi 
?ed RXR ligand binding domain and a transactivation 
domain capable of activating the promoter of the gene-of 
interest expression cassette. The ?rst polypeptide and the 
second polypeptide dimeriZe in the presence of the ligand. 
The DNA-binding domain binds the response element of the 
gene-of-interest expression cassette, While the transactivation 
domain activates the promoter of the gene-of-interest expres 
sion cassette. In this manner, When the ?rst and second 
polypeptides dimeriZe in the presence of the ligand expres 
sion of the gene-of-interest is affected. 
With reference to FIG. 1, in some embodiments of the 
presently-disclosed subject matter, a system 10 for modulat 
ing expression of a gene-of-interest 30 in a host plant cell 
includes: an EcR gene expression cassette 12, and an RXR 
gene expression cassette 14, both of Which are capable of 
being expressed in a host plant cell and both of Which are 
under the control of constitutive promoters 16, 18. The sys 
tem 10 also includes a gene-of-interest expression cassette 20 
for expressing the gene-of-interest 30 in the host plant cell. 
The EcR gene expression cassette 12 includes a ?rst poly 
nucleotide encoding a ?rst polypeptide 22, Which includes a 
ligand-binding domain 24 and a DNA-binding domain 26, for 
recogniZing a response element 28 of the gene-of-interest 
expression cassette 20. The ligand-binding domain 24 of the 
?rst polypeptide 22 can include an ecdysone receptor ligand 
binding domain. 
The EcR ligand binding domain have the sequence of a 
Wild type Chorisloneurafurniferana (spruce budWorm) EcR 
(CfEcR) ligand binding domain or another EcR ligand bind 
ing domain selected from the group including, but not limited 
to: a moth EcR, a butter?y EcR, a ?y EcR, a mosquito EcR, a 
beetle EcR, a locust EcR, a White?y EcR, a fruit ?y EcR, a 
honey bee EcR, and a leaf hopper EcR. 
In some embodiments, the EcR ligand binding domain 
includes tWelve helices. In some embodiments the EcR ligand 
binding domain is a truncated EcR ligand binding domain. A 
truncated EcR refers to an EcR that includes feWer residues 
than a full-length Wild type EcR. The term “truncated” When 
used to refer to a polypeptide refers to an amino acid sequence 
Wherein one or more amino acids have been removed relative 
to a reference polypeptide. For example, With reference to 
GENBANK® Accession Number AAC36491 of the full 
length 541 amino acid EcR, in some embodiments, a trun 
cated EcR Will include at least amino acids 196-541 of the 
full-length EcR. In some embodiments, a truncated EcR Will 
include at least 350, 375, 400, 425, 450, 475, 500, or 525 
amino acids. 
The DNA binding domain and the response element should 
be selected as a pair, such that the DNA binding domain that 
is selected Will recogniZe the response element that is 
selected; hoWever, so long as the selected DNA binding 
domain recogniZes the selected response element, any such 
pair may be selected, i.e., any DNA binding domain With a 
knoWn response element Will Work, and conversely, any 
response element With a knoWn DNA binding domain Will 
Work. For example, in some embodiments, the DNA binding 
domain (DBD) and response element (RE) are selected from: 
GAL4 147 DBD and RE; GAL4 65 DBD and RE; GAL4 93 
DBD and RE; LexA DBD and RE; Lac repressor DBD and 
RE. 
In some embodiments, the EcR gene expression cassette is 
under the control of a constitutive promoter. In some embodi 
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ments, the constitutive promoter is selected from the group 
consisting of a 35S promoter, a CaMv promoter, and a CSV 
promoter. In some embodiments, the constitutive promoter is 
a 35S promoter. 
With continued reference to FIG. 1, the RXR gene expres 
sion cassette 14 encodes a second polypeptide 32 having a 
transactivation domain 34. The transactivation domain used 
for the gene sWitch can also be selected from a variety of 
alternative transactivation domains, so long as the selected 
transactivation domain is capable of activating the promoter 
being used in the gene-of-interest expression cassette. 
Examples of transactivation domains that can be used 
include, but are not limited to, the folloWing: a VP16 activa 
tion domain; a truncated or minimal VP16 transactivation 
domain containing core activation domain residues (single or 
multiple copies); a GAL4 transactivation domain; p53 trans 
activation domains; p65 Subunit of NF-kb activation domain; 
and the like. 
The second polypeptide 32 expressed by the RXR gene 
expression cassette 14 further includes a ligand binding 
domain of a modi?ed RXR 42. The term “modi?ed” When 
used to refer to a polypeptide refers to an amino acid sequence 
that is different from a reference polypeptide by one or more 
amino acids, e.g., one or more amino acid substitutions or 
mutations. The modi?ed RXR 42 can comprise a polypeptide 
sequence of SEQ ID NO: 1 that has been modi?ed With at 
least one amino acid mutation. SEQ ID NO: 1 has the amino 
acid sequence of a 1-8 helices region of RXR from Wild type 
Locusla migraloria (LHTDM PVERI LEAEK RVECK 
AENQV EYELV EWAKH IPHFT SLPLE DQVLL LRAGW 
NELLI AAFSH RSVDV KDGIV LATGL TVHRN SAHQA 
GVGTI FDRVL TELVA KMREM KMDKT ELGCL RSVIL 
FNPE). 
In some embodiments, the modi?ed RXR ligand binding 
domain can include the amino acid sequence of 1-12 helices 
of an RXR, including at least one amino acid mutation in the 
portion of the RXR ligand binding domain corresponding to 
the 1-8 helices region, e.g., SEQ ID NO: 1. In some embodi 
ments, the modi?ed RXR ligand binding domain is a trun 
cated modi?ed RXR ligand binding domain. For example, 
With reference to GENBANK® Accession Number 
AAQ55293 for Wild type LmRXR, a modi?ed RXR ligand 
binding domain can include the Wild type amino acid 
sequence With one or more amino acid mutations, and a 
truncated RXR ligand binding domain can include the Wild 
type amino acid sequence With one or more amino acids 
deletions. 
Examples of amino acid mutations in the portion of the 
RXR ligand binding domain corresponding to SEQ ID NO: 1 
include, but are not limited to, the folloWing: S122A; A105S; 
T94A; T81H; A62S; A62S1T81H; and A62S1T81H1V123I. 
Although the portion of the RXR corresponding to the 1-8 
helices region of RXR Will often have the sequence of SEQ ID 
NO: 1 With at least one amino acid mutation, remaining 
portions of the RXR (e.g., 9-12 helices region) can have the 
sequence of an RXR that is selected from: a migratory locust 
RXR, a mouse RXR, a honey bee RXR, a beetle RXR, a 
White?y RXR, or a leaf hopper RXR. In some embodiments, 
the RXR is not a human RXR. In some embodiments, the 
RXR is from a migratory locust (Locusta migratoria) RXR 
(LmRXR). 
In some embodiments, the modi?ed RXR gene expression 
cassette is under the control of a constitutive promoter. In 
some embodiments, the constitutive promoter is selected 
from the group consisting of a 35S promoter, a CaMv pro 
moter, and a CSV promoter. In some embodiments, the con 
stitutive promoter is a 35S promoter. 
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With continued reference to FIG. 1, in the presence of a 
ligand 36 recognized by the ligand-binding domain 24 of the 
?rst polypeptide 22, the ?rst polypeptide 22 and the second 
polypeptide 32 dimeriZe 38. The DNA-binding domain 26 
binds the response element 28 of the gene-of-interest expres 
sion cassette 20. The gene-of-interest expression cassette 20 
also includes a promoter 40 that is activated by the transacti 
vation domain 34. As such, When the polypeptides 22, 32 
dimeriZe 38, the DNA-binding domain 26 binds the response 
element 28 and the transactivation domain 34 activates the 
promoter 40 of the gene-of-interest expression cassette 20, 
thereby affecting expression of the gene-of-interest. 
Examples of ligands that can be used With the system 
include any ligand capable of binding the ligand binding 
domain and affecting modulation of the gene-of-interest in 
the system of the present invention, including methoxy 
fenoZide, tubefenoZide, halo fenoZide, chromofenoZide, dia 
cylhydraZine compounds, and the like. 
In some embodiments, the gene-of-interest expression cas 
sette 20 of the system 10 further includes a translational 
optimiZation sequence 44. The translational optimiZation 
sequence 44 can be placed betWeen the promoter 40 and the 
gene-of-interest 30. The translational optimization sequence 
44 can include coding and non-coding portions, such that, in 
some embodiments, the polypeptide product of the gene-of 
interest 30 can include amino acid residues coded by the 
translational optimiZation sequence 44 portion of the gene 
of-interest expression cassette 20. For example, in some 
embodiments the translational optimiZation sequence 44 can 
be AACAATGGA, Wherein the ?rst amino acid residues of 
the polypeptide product of the gene-of-interest 30 is methion 
ine (coded by ATG, amino acids 5-7 of the translational 
optimiZation sequence). 
The system of the presently-disclosed subject matter can 
be used to practice a method of modulating the expression of 
a gene-of-interest inplants. The ability to so modulate expres 
sion of a gene-of-interest in plants is useful, for example, to 
investigate gene function or to select predetermined plants in 
an agricultural setting Without the use of herbicides and/or 
pesticides. Any gene Whose function is desired to be investi 
gated or of Which the expression is desired to be modulated 
may be selected for expression modulation in accordance 
With the method of the presently-disclosed subject matter. 
As such, the presently-disclosed subject matter further 
includes a method of modulating expression of a gene-of 
interest in a host plant cell. In some embodiments, the method 
includes introducing into the host plant cell an EcR gene 
expression cassette for expressing a ?rst polypeptide as 
described herein above, an RXR gene expression cassette for 
expressing a second polypeptide as described herein above, 
and a gene-of-interest expression cassette as described herein 
above; and introducing into the host plant cell a ligand that 
binds a ligand-binding domain of the ?rst polypeptide; 
Wherein the ?rst polypeptide and the second polypeptide 
dimeriZe in the presence of the ligand and affect expression of 
the gene-of-interest. The expression cassettes may be intro 
duced into plant host cells by methods knoWn to those skilled 
in the art. 
The presently-disclosed subject matter further includes an 
isolated nucleic acid and an isolated polypeptide. The term 
“isolated”, When used in the context of an isolated nucleic 
acid molecule or an isolated polypeptide, is a nucleotide or 
polypeptide that, by the hand of man, exists apart from its 
native environment and is therefore not a product of nature. 
An isolated nucleic acid molecule or polypeptide can exist in 
a puri?ed form or can exist in a non-native environment such 
as, for example, in a transgenic host cell. 
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In some embodiments, the presently-disclosed subject 
matter includes an isolated nucleic acid comprising a 
sequence that encodes a polypeptide comprising SEQ ID NO: 
1 With at least one amino acid mutation. In some embodi 
ments, the at least one amino acid mutation is selected from 
the group consisting of: S122A; A105S; T94A; T81H;A62S; 
A62S1T81H; and A62S1T81H1V123I. 
In some embodiments, the presently-disclosed subject 
matter includes an isolated polypeptide comprising SEQ ID 
NO: 1 With at least one amino acid mutation. In some embodi 
ments, the at least one amino acid mutation is selected from 
the group consisting of: S122A; A105S; T94A; T81H;A62S; 
A62S1T81H; and A62S1T81H1V123I. 
The presently-disclosed subject matter is further illustrated 
by the folloWing speci?c but non-limiting examples. The 
folloWing examples may include compilations of data that are 
representative of data gathered at various times during the 
course of development and experimentation related to the 
present invention. 
EXAMPLES 
Chemically inducible gene regulation systems have appli 
cations for the precise regulation of transgene expression in 
plants and animals. Recent advancement in a tWo hybrid 
ecdysone receptor (EcR) based gene sWitch in host animal 
cells Was achieved using a chimera, identi?ed as chimera 
9(CH9), betWeen Homo sapiens retinoid x receptor (HsRXR) 
and insect, Locusla migraloria RXR (LmRXR) as partner 
With Chorisloneura fumiferana EcR (CfEcR) in inducing 
expression of the luciferase reporter gene (Tavva et al. 2007). 
The tWo hybrid gene sWitch containing chimera 9 (CH9) 
along With CfEcR Was useful in terms of loW-background 
activity in the absence of ligand and high induced expression 
levels of the reporter gene in the presence of ligand. An 
attempt for host plant cell use of the gene sWitch including 
chimera 9, Which involved the use of human RXR and 
LmRXR, Wouldhave at least bio-safety and social acceptance 
issues. These examples include descriptions of studies related 
to embodiments of the presently-disclosed gene sWitches that 
have bene?ts comparable to, Without certain draWbacks asso 
ciated With, the CH9-containing gene sWitch. 
Each of the exemplary embodiments of the gene sWitch 
described in these examples is a tWo hybrid EcR gene sWitch 
containing LmRXR as its partner, Where there is at least one 
amino acid mutation in the amino acids residues of the 1-8 
helices of LmRXR. The amino acid sequence of the 1-8 
helices of LmRXR is identi?ed as SEQ ID NO: 1. The exem 
plary embodiments also include a translational optimiZation 
polynucleotide sequence upstream of the coding rejoin of the 
gene Whose expression is modulated. The folloWing 
sequences Were tested for use as a translational optimiZation 
polynucleotide sequence: AACAATGGA, AAAAATGGA, 
and AACCATGGA. As shoWn in these examples, the exem 
plary embodiments of the gene sWitch has very loW back 
ground expression in the host plant cells in the absence of 
ligand, and high induction of luciferase reporter in the host 
plant cells at loW concentrations of ligand, e.g., as loW as 
about 16-80 nM concentrations. 
Materials and Methods 
Various LmRXR mutants Were generated by changing 
amino acids residues in 1-8 helices by site-directed mutagen 
esis. The folloWing mutants Were generated: S122A (Lml); 
A105S (Lm2); T94A (Lm3); T81H (Lm4); A62S (Lm5); 
A62S1T81H (Lm6); A62S1T81H1V123I (Lm7). These 
mutants are collectively referred to in these examples as the 
LmRXR mutants. 
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Site-directed mutagenesis Was carried out by using the 
quick change site-directed mutagenesis kit (Stratagene). 
Mutations Were veri?ed by sequencing. Several sets of prim 
ers Were used to change the amino acids residues in 1-8 
helices of LmRXR corresponding to HsRXR. These primers 
included: 
LmS122A (F) 5'-CTT GGC TGC TTG CGA GCT GTT 
ATT CTT TTC AAT CC-3' (SEQ ID NO: 2) 
LmS122A (R) 5' GGA TTG AAA AGA ATA ACA GCT 
CGC AAG CAG CCA AG-3' (SEQ ID NO: 3) 
LmA105S (F) 5' TTGACA GAA CTG GTA TCAAAGAT 
GAGA GAA ATG-3'(SEQ ID NO: 4) 
LmA105S (R) 5' CAT TTC TCT CAT CTT TGA TAC 
CAG TTC TGT CAA-3' (SEQ ID NO: 5) 
LmT94A (F) 5' CAA GCT GGA GTC GGC GCA ATA 
TTT GAC AGA GTT TTG-3' (SEQ ID NO: 6) 
LmT94A (R) 5' CAA AAC TCT GTC AAA TAT TGC 
GCC GAC TCC AGC TTG-3' (SEQ ID NO: 7) 
LmT81H (F) 5' CTT GCC ACT GGT CTC CAC GTG CAT 
CGA AAT TCT GCC-3' (SEQ ID NO: 8) 
LmT81H (R) 5' GGC AGA ATT TCG ATG CAC GTG 
GAG ACC AGT GGC AA-3' (SEQ ID NO: 9) 
LmA62S (F) 5' GAA CTG CTAATT GCA TCA TTT TCA 
CAT CGA TCT G-3' (SEQ ID NO: 10) 
Lm A62S (R) 5' CAG ATC GAT GTG AAA ATG ATG 
CAA TTA GCA GTT C-3' (SEQ ID NO: 11) 
LmV123l (F) 5' TGG CTG CTT GCG ATC TAT TAT TCT 
TTT CAA TCC-3' (SEQ ID NO: 12) 
Lm V1231 (R) 5' GGA TTG AAA AGA ATA GAT CGC 
AAG CAG CCA-3' (SEQ ID NO: 13) 
For transient expression studies, the LmRXR mutants 
receptor and reporter (-46 35S:Luc/—46 35S:KLuc/—31 35S: 
KLuc) gene expression cassettes Were cloned into the 
pKYLX80 vector. The LmRXR mutants Were cloned doWn 
stream of the VP16 AD sequence in pVP16 vector (BD Bio 
sciences Clonetech, San Jose, Calif., USA). DNA sequences 
coding for the fusion proteins of VP16 AD and RXR mutants 
Were transferred from pVP16RXR mutant constructs using 
Nhel and Xbal restriction endonucleases and cloned into the 
Xbal restricted pKYLX80 vector. The resulting constructs 
Were designated pK80Lm-1-pK80Lm-7. A detailed descrip 
tion of the construction of pK80GCfE Was described in detail 
by Tavva et al. (2006). 
KoZak sequences Were placed upstream to the luciferase 
reporter gene and screened for better transgene expression in 
plants. For the reporter expression cassette, —46 and —31 35S 
minimal promoters Were cloned into pKYLX80 vector as 
described by Tavva et al. (2006). The luciferase reporter gene 
Was PCR-ampli?ed from the pFRLuc vector (Stratagene, La 
Jolla, Calif., USA) using several sets of primers having dif 
ferent KoZak sequence and cloned into pGEM-T Easy vector 
to verify the integration of KoZak sequences sequence. These 
primers included: 
KZKLUC2 (F): 5'-CTC GAGAAAAAT GGA AGA CGC 
CAAAAA CAT AAA G-3' (SEQ ID NO: 14) 
KZKLUC4 (F): 5'-CTC GAG AAC CAT GGA AGA CGC 
CAAAAA CAT AAA G-3' (SEQ ID NO: 15) 
KZKLUCl (F): 5'-CTC GAG AAC AAT GGA AGA CGC 
CAAAAA CAT AAA G-3' (SEQ ID NO: 16) 
The luciferase reporter gene With KoZak sequence Was then 
excised from the pGEM-T Easy vector and cloned into Xhol/ 
Sacl sites doWnstream of the minimal —46 35S minimal pro 
moter in the modi?ed pKYLX80 vector. The reporter gene 
expression cassette With the pKYLX80 background Was des 
ignated as pK80-46 35S:KLuc. The full-length luciferase 
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gene Was cloned into the pKYLX80 vector under the control 
of the CaMV 35S2 promoter and used as a positive control in 
transient expression studies. 
Binary vectors for stable transformation of Arabidopsis 
Zhaliana Were constructed in pCAMBlA2300 vectors (CAM 
BIA, Can berra, Australia). To construct the binary vector for 
plant transformation, the GAL4 DBD:CfEcR fusion gene 
Was cloned under the ?gWort mosaic virus (FMV) promoter 
and Ubiquitin 2 (Ubi) terminator sequence and the VP1 6 AD: 
mutant Lm-1-Lm-7 fusion gene Were cloned under the mira 
bilis mosaic virus (MMV) promoter and Agrobaclerium 
Zumefaciens octopine synthase (Ocs) poly A sequence. The 
FMV- and MMV-driven expression cassettes Were assembled 
into pSL301 vector. The reporter and receptor expression 
cassettes Were excised With appropriate restriction enzymes 
and assembled into the pCAMBlA2300 vector for plant 
transformation. The resulting binary vector Was designated as 
p2300:Lm7:luc (FIG. 2). 
Transient expression studiesiTransient expression stud 
ies Were carried out by isolating protoplasts from cell suspen 
sion cultures of tobacco (Nicoliana Zabacum cv. Xanthi 
Brad). A detailed description of the isolation and 
electroporation of protoplasts Was described earlier by Tavva 
et al. (2006). 
Dose response study With tobacco protoplastsiMethoxy 
fenoZide dose-dependent performance of different LmRXR 
mutants (Lm-1-Lm-7) in inducing luciferase reporter gene 
activity in a tWo-hybrid gene sWitch Was tested by co-elec 
troporating pK80-46 35S:KLuc, pK80GCfE, and mutant 
LmRXR (pK80VLm1-Lm7) constructs. The electroporated 
protoplasts Were incubated in the groWth medium containing 
0, 0.64, 3.2, 16, 80, 400, 2000, 10 000 nM concentrations of 
methoxyfenozide. After 24 h of addition of ligand, the proto 
plasts Were assayed for luciferase reporter gene activity using 
a Fluoroscan FL plate reader (FluoroscanAscent FL, Thermo 
biosystems Milford, Mass., USA) as described earlier 
(Tavva et al. 2006). 
Plant tissue cultureiArabidopsis Zhaliana (L.) Heynth. 
ecotype Columbia ER Was used for plant transformation 
experiments. The binary vector (p2300 CfEcR:LmRXR 
mutant (Lm-1-Lm-7): Luc) constructs for plant transforma 
tion Was mobiliZed into Agrobaclerium Zumefaciens, strain 
GV3850 by freeZe-thaW method. Arabidopsis plants Were 
transformed using the Whole plant-dip method (Clough and 
Bent 1998). Transgenic Arabidopsis plants Were selected by 
germinating the seeds collected from the in?ltrated plants on 
medium containing 50 mg/l kanamycin. The analysis of 
transgenic plants for luciferase induction level Was carried 
out on T2 seeds plated on kanamycin containing medium. 
Dose response study With T2 Arabidopsis plantsiSeeds 
collected from four T2 Arabidopsis lines Were plated on agar 
media containing 50 mg/l kanamycin and different concen 
trations of methoxyfenoZide (0, 0.64, 3.2, 16, 80, 400, 2000, 
10 000 nM). The seeds Were alloWed to germinate and greW 
on the induced media for 20 days at 250 C., 16 h light/8-h 
dark. Three seedlings from each plate Were collected sepa 
rately and ground in a volume of 100 pl of 1x passive lyses 
buffer (Promega corporation, Madison, Wis., USA) and 
luciferase activity Was measured. 
Soil Applications of MethoxyfenoZide 
Time-course and study With soil-groWn plantsiT2 Arabi 
dopsis plants Were transferred to a greenhouse in a time 
course study involving the application of 0, 0.64, 3.2, 16, 80, 
400, 2000, 10 000 nM methoxyfenoZide to the soil. Care Was 
taken not to leach out any excess solution. Leaf discs Were 
collected at 0, 1, 2, and 4 days after application of methoxy 
fenoZide and luciferase activity in each leaf disk Was mea 
sured. 






